RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com
  

Ganymed Pharmaceuticals Ag patents

Recent patent applications related to Ganymed Pharmaceuticals Ag. Ganymed Pharmaceuticals Ag is listed as an Agent/Assignee. Note: Ganymed Pharmaceuticals Ag may have other listings under different names/spellings. We're not affiliated with Ganymed Pharmaceuticals Ag, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Ganymed Pharmaceuticals Ag-related inventors




Date Ganymed Pharmaceuticals Ag patents (updated weekly) - BOOKMARK this page
04/13/17Genetic products differentially expressed in tumors and use thereof
03/02/17Monoclonal antibodies for treatment of cancer
01/19/17Claudin-6-specific immunoreceptors and t cell epitopes
12/08/16Cancer therapy using cldn6 target-directed antibodies in vivo
11/24/16Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
11/17/16Antibodies against claudin 18.2 useful in cancer diagnosis
09/22/16Agents for treatment of claudin expressing cancer diseases
09/15/16Antibodies for treatment of cancer expressing claudin 6
08/04/16Antibodies specific for claudin 6 (cldn6)
07/07/16Identification of surface-associated antigens for tumor diagnosis and therapy
06/30/16Monoclonal antibodies against claudin-18 for treatment of cancer
06/30/16Monoclonal antibodies for treatment of cancer
06/09/16Diagnosis and therapy of cancer involving cancer stem cells
02/25/16Identification of tumour-associated cell surface antigens for diagnosis and therapy
01/14/16Therapy involving antibodies against claudin 18.2 for treatment of cancer
12/31/15Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
12/24/15Identification of surface-associated antigens for tumor diagnosis and therapy
11/05/15Genetic products differentially expressed in tumors and the use thereof
09/10/15Monoclonal antibodies against claudin-18 for treatment of cancer
09/10/15Monoclonal antibodies against claudin-18 for treatment of cancer
07/16/15Identification of tumor-associated antigens for diagnosis and therapy
06/25/15Monoclonal antibodies for treatment of cancer
06/11/15Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
05/28/15Antibodies against claudin 18.2 useful in cancer diagnosis
05/14/15Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
01/29/15Genetic products differentially expressed in tumors and use thereof
07/17/14Immunotherapeutic methods using epitopes of wt-1 and gata-1
05/08/14Antibodies for treatment of cancer
10/11/12Genetic products differentially expressed in tumors and the use thereof
08/02/12Monoclonal antibodies against claudin-18 for treatment of cancer
06/28/12Monoclonal antibodies against claudin-18 for treatment of cancer
06/28/12Compositions and methods for therapy and diagnosis of cancer
06/09/11Identification of tumour-associated cell surface antigens for diagnosis and therapy
01/20/11Identification of surface-associated antigens for tumor diagnosis and therapy
09/03/09Compositions and methods for therapy and diagnosis of cancer







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ganymed Pharmaceuticals Ag in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ganymed Pharmaceuticals Ag with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';